[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100573033":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":20,"responsibleParty":31,"collaborators":20,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":39,"acronym":20,"eligibilityCriteria":40,"healthyVolunteers":37,"sex":41,"minAge":42,"maxAge":20,"enrollmentInfo":43,"targetDuration":20,"studyType":46,"phases":47,"briefSummary":49,"conditions":50,"keywords":54,"overallStatus":58,"whyStopped":20,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":20},{"fullName":5,"class":6},"Istanbul University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Single arm study using ICG as a sentinel lymph node agent in early stage endometrium cancer","EXPERIMENTAL","Single arm study using ICG as a sentinel lymph node agent to detect the location of SLN in correlation with the presence or absence of superficial or deep uterine vein in early stage endometrial cancer",[13],"Procedure: Retroperitoneal pelvic lymphatic and uterine vessel dissection",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"PROCEDURE","Retroperitoneal pelvic lymphatic and uterine vessel dissection","ICG injection to cervix uteri at 3 and 9 o'clock followed by laparoscopic dissection of retroperitoneal space to detect uterine vessels (uterine arteries, SUVs and DUVs) bilaterally in addition to detect the location and biopsy of SLN stained by ICG.",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Mustafa Albayrak, MD,Gynecologic Oncology Fellow","CONTACT","+90 532 6871051","mustafaalbayrak@icloud.com",{"name":28,"role":24,"phone":29,"phoneExt":20,"email":30},"Yagmur Minareci, M.D.,Gynec. Oncol Specialist","+905053574361","yagmurminareci@gmail.com",{"type":32,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Mustafa Albayrak","Principal Investigator","100573033","correlation-of-pelvic-sentinel-lymph-node-with-superficial-vein-100573033",false,"NCT06741007","Correlation of Pelvic Sentinel Lymph Node With Superficial Vein","Inclusion Criteria:\n\n* all women with early stage endometrial cancer who will be operated for staging\n\nExclusion Criteria:\n\nPrevious radiotheraphy Previous pelvic retropelvic LN dissection Women with any disease that precludes pelvic retropelvic LN dissection (such as peritoneal dialysis)\n\n\\-","FEMALE","18 Years",{"count":44,"type":45},100,"ESTIMATED","INTERVENTIONAL",[48],"NA","Pelvic Sentinel Lymph Node (SLN) biopsy is an important integral part of endometrial surgery. Although SLN is usually found on internal iliac artery, location is variable. Lymphatic pathways in pelvis determines the location (Obturator, internal iliac or external iliac vessel locations). Since it is accepted that the lymphatic channel formation during embryologic life follows venous system formation investigators hypothesized that the presence or absence of superior or deep uterine vein may determine the location of sentinel lymph node",[51,52,53],"Sentinel Lymph Node","Superficial Uterine Vein","Deep Uterine Vein",[55,56,57],"sentinel lymph node","uterine vein","uterine artery","NOT_YET_RECRUITING","2024-12-15",{"date":61,"type":62},"2024-12-18","ACTUAL",{"date":64,"type":45},"2024-12-22",{"date":66,"type":45},"2026-09-15",{"name":5,"class":6}]